SB-206553
Chemical compound
From Wikipedia, the free encyclopedia
SB-206553 is a drug which acts as a mixed antagonist for the 5-HT2B and 5-HT2C serotonin receptors.[1][2][3]
 | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C17H16N4O |
| Molar mass | 292.342 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Usage
It has anxiolytic properties in animal studies and interacts with a range of other drugs.[4][5][6][7][8][9][10][11][12] It has also been shown to act as a positive allosteric modulator of α7 nicotinic acetylcholine receptors.[13] Modified derivatives of SB-206553 have been used to probe the structure of the 5-HT2B receptor.[14]
Development
SB-206553 was under development by GlaxoSmithKline for the treatment of anxiety disorders in the 1990s.[15] However, its development was discontinued in 1996.[15]
